Literature DB >> 6315123

Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.

G Lane, N C Siddle, T A Ryder, J Pryse-Davies, R J King, M I Whitehead.   

Abstract

Oral progesterone 100, 200, or 300 mg daily was given for the first 10 days of each calendar month to postmenopausal women also receiving conjugated oestrogens 1.25 mg daily continuously. Endometrial biopsy specimens were taken on the sixth day of the third or subsequent cycle of combined treatment for histological, ultrastructural, and biochemical evaluation. Secretory histological changes were induced within the endometrium in a dose dependent manner, as were progesterone sensitive ultrastructural features such as nucleolar channel systems, giant mitochondria, and subnuclear accumulations of glycogen. Dose response relations were also observed for suppression of DNA synthesis and nuclear oestrogen receptor, and for induction of the activities of oestradiol and isocitric dehydrogenases. Progesterone administered by mouth clearly provokes an end organ response within the endometrium. Suboptimal effects were observed with the lower doses but progesterone 300 mg daily achieved responses approaching and within the physiological range. This dose may therefore be effective as an alternative to synthetic progestogens for therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315123      PMCID: PMC1549751          DOI: 10.1136/bmj.287.6401.1241

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  22 in total

1.  Effects of norethindrone on carbohydrate and lipid metabolism.

Authors:  W N Spellacy; W C Buhi; S A Birk
Journal:  Obstet Gynecol       Date:  1975-11       Impact factor: 7.661

2.  Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.

Authors:  D D Bradley; J Wingerd; D B Petitti; R M Krauss; S Ramcharan
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

3.  James Mackenzie Lecture 1979. The happiness pill?

Authors:  C R Kay
Journal:  J R Coll Gen Pract       Date:  1980-01

4.  Effect of estrogen and progestin treatments on endometria from postmenopausal women.

Authors:  R J King; M I Whitehead; S Campbell; J Minardi
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

5.  Absorption and metabolism of oral progesterone.

Authors:  M I Whitehead; P T Townsend; D K Gill; W P Collins; S Campbell
Journal:  Br Med J       Date:  1980-03-22

6.  Effects of various types and dosages of progestogens on the postmenopausal endometrium.

Authors:  M I Whitehead; P T Townsend; J Pryse-Davies; T Ryder; G Lane; N C Siddle; R J King
Journal:  J Reprod Med       Date:  1982-08       Impact factor: 0.142

7.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

8.  The prevention of endometrial cancer in postmenopausal women with progestogens.

Authors:  R D Gambrell
Journal:  Maturitas       Date:  1978-09       Impact factor: 4.342

9.  Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.

Authors:  T W Meade; G Greenberg; S G Thompson
Journal:  Br Med J       Date:  1980-05-10

10.  Biochemical studies on human and rat breast tissues.

Authors:  J A Smith; R J King; B F Meggitt; L N Allen
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

View more
  7 in total

Review 1.  Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception.

Authors:  Frank Z Stanczyk
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 2.  [The role of progestins].

Authors:  H I Wyss
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

Review 3.  Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis.

Authors:  Yun Fu; Zhigang Zhuang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Progesterone and Breast Cancer: an NCI Workshop Report.

Authors:  Neeraja Sathyamoorthy; Carol A Lange
Journal:  Horm Cancer       Date:  2020-02       Impact factor: 3.869

5.  Progesterone and the premenstrual syndrome: a double blind crossover trial.

Authors:  L Dennerstein; C Spencer-Gardner; G Gotts; J B Brown; M A Smith; G D Burrows
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-01

Review 6.  Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Authors:  Frank Z Stanczyk; Janet P Hapgood; Sharon Winer; Daniel R Mishell
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

Review 7.  Sex steroids and cancer in older women.

Authors:  T R Varma
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.